Dr. Baritaki is currently an Assistant Professor of Experimental Oncology, Division of Surgery, Medical School at the University of Crete, Greece. She earned her Masters and Ph.D degrees in Molecular Biology and Biomedicine from the Biology Department of the same University. She had long postdoctoral training on Tumor Immunobiology in the University of Heidelberg, Germany, and the Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). From 2011 to 2016, Dr. Baritaki had been holding appointments as an Assistant Researcher and a Junior Faculty in the Division of Digestive Diseases at UCLA Medical School, USA. Her research interests mainly focus on 1) understanding the underlying molecular mechanisms of tumor resistance to conventional chemo/immunotherapies and immuno-mediated cytotoxicity, as well as exploring the molecular basis of the early metastatic steps (EMT), 2) identifying novel gene signatures with prognostic and therapeutic significance in οncology, 2) characterizing novel chemo/immuno-therapeutics with sensitizing activities against solid and hematological malignancies resistant to conventional therapies.
Dr Baritaki’s academic profile and bibliography are available at https://scholar.google.com/citations?user=3g2D6iIAAAAJ and https://www.ncbi.nlm.nih.gov/pubmed/?term=baritaki+s+or+baritakis+s.